Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Diseases

Background:

• Nonfunctioning adrenal incidentalomas (NFAIs) are adrenal tumors not producing excess hormones.
• The association between NFAIs and cardiometabolic diseases like diabetes and hypertension is not fully understood.
• This study aimed to clarify the relationship between NFAIs and prevalent/incident cardiometabolic diseases.

Purpose of the Study:

• To investigate the association between nonfunctioning adrenal incidentalomas (NFAIs) and prevalent cardiometabolic diseases.
• To determine if NFAIs increase the risk of developing new cardiometabolic diseases over time.
• To compare cardiometabolic disease prevalence and incidence in patients with NFAIs versus controls.

Main Methods:

• Retrospective cohort study comparing 154 patients with NFAIs to 462 matched controls.
• Data collected via electronic medical records for comorbidities at baseline and during a mean 7.5-year follow-up.
• Logistic regression for prevalent diseases and survival analysis for incident diseases.

Main Results:

• NFAI patients had higher BMI, diabetes mellitus, hypertension, and insulin resistance compared to controls.
• Adjusted odds ratios showed significantly higher odds for diabetes (1.89) and hypertension (2.26) in the NFAI group.
• No significant difference in the incidence of new cardiometabolic diseases between NFAI and control groups.

Conclusions:

• NFAIs are associated with prevalent diabetes mellitus and hypertension.
• The presence of NFAIs did not predict the future development of cardiometabolic diseases.
• Further research may explore the underlying mechanisms linking NFAIs to existing cardiometabolic conditions.